152 related articles for article (PubMed ID: 33785250)
1. Impact of carfilzomib-based desensitization on heart transplantation of sensitized candidates.
Sriwattanakomen R; Xu Q; Demehin M; Shullo MA; Mangiola M; Hickey GW; Sciortino CM; Horn ET; Keebler ME; Zeevi A
J Heart Lung Transplant; 2021 Jul; 40(7):595-603. PubMed ID: 33785250
[TBL] [Abstract][Full Text] [Related]
2. Does bortezomib influence pre-transplant desensitization therapy or benefit post-heart transplant outcomes for highly sensitized patients?
Dhillon M; Kobashigawa JA; Kittleson M; Jain R; Patel N; Singer-Englar T; Zhang X; Hakimi M; Aintablian T; Vescio R; Dilibero D; Kransdorf E; Czer L; Nikolova AP; Patel JK
Clin Transplant; 2024 Jan; 38(1):e15165. PubMed ID: 37837612
[TBL] [Abstract][Full Text] [Related]
3. Analysis of anti-HLA antibodies in sensitized kidney transplant candidates subjected to desensitization with intravenous immunoglobulin and rituximab.
Lobashevsky AL; Higgins NG; Rosner KM; Mujtaba MA; Goggins WC; Taber TE
Transplantation; 2013 Jul; 96(2):182-90. PubMed ID: 23778648
[TBL] [Abstract][Full Text] [Related]
4. Pretransplant Desensitization with Costimulation Blockade and Proteasome Inhibitor Reduces DSA and Delays Antibody-Mediated Rejection in Highly Sensitized Nonhuman Primate Kidney Transplant Recipients.
Ezekian B; Schroder PM; Mulvihill MS; Barbas A; Collins B; Freischlag K; Yoon J; Yi JS; Smith F; Olaso D; Saccoccio FM; Permar S; Farris AB; Kwun J; Knechtle SJ
J Am Soc Nephrol; 2019 Dec; 30(12):2399-2411. PubMed ID: 31658991
[TBL] [Abstract][Full Text] [Related]
5. A prospective, iterative, adaptive trial of carfilzomib-based desensitization.
Tremblay S; Driscoll JJ; Rike-Shields A; Hildeman DA; Alloway RR; Girnita AL; Brailey PA; Woodle ES
Am J Transplant; 2020 Feb; 20(2):411-421. PubMed ID: 31550069
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of bortezomib desensitization among heart transplant candidates.
Brinkley DM; Mangione M; Fossey SC; Harrison KM; Zalawadiya S; Rali AS; Siddiqi HK; Lindenfeld J; Schlendorf KH
Clin Transplant; 2023 Apr; 37(4):e14907. PubMed ID: 36661196
[TBL] [Abstract][Full Text] [Related]
7. Outcome of Desensitization Therapy in Immunologically High-Risk Kidney Transplantation: Single-Center Experience.
Sinangil A; Ucar ZA; Koc Y; Barlas S; Abouzahir S; Ecder ST; Akin EB
Transplant Proc; 2019 Sep; 51(7):2268-2273. PubMed ID: 31358450
[TBL] [Abstract][Full Text] [Related]
8. HLA desensitization with bortezomib in a highly sensitized pediatric patient.
May LJ; Yeh J; Maeda K; Tyan DB; Chen S; Kaufman BD; Bernstein D; Rosenthal DN; Hollander SA
Pediatr Transplant; 2014 Dec; 18(8):E280-2. PubMed ID: 25174602
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of combined plasma cell therapy and costimulation blockade based desensitization regimen in heart transplant candidates.
Fida N; Eagar TN; Yun AN; Rogers AW; Nguyen DT; Graviss EA; Ishaq F; DiPaola NR; Kim J; Janardhana G; Kassi M; Yousefzai R; Suarez EE; Bhimaraj A; Krisl JC; Guha A
Clin Transplant; 2024 Feb; 38(2):e15249. PubMed ID: 38369810
[TBL] [Abstract][Full Text] [Related]
10. Antibody desensitization therapy in highly sensitized lung transplant candidates.
Snyder LD; Gray AL; Reynolds JM; Arepally GM; Bedoya A; Hartwig MG; Davis RD; Lopes KE; Wegner WE; Chen DF; Palmer SM
Am J Transplant; 2014 Apr; 14(4):849-56. PubMed ID: 24666831
[TBL] [Abstract][Full Text] [Related]
11. Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients.
Zeevi A; Lunz J; Feingold B; Shullo M; Bermudez C; Teuteberg J; Webber S
J Heart Lung Transplant; 2013 Jan; 32(1):98-105. PubMed ID: 23142561
[TBL] [Abstract][Full Text] [Related]
12. Reduction of alloantibodies via proteasome inhibition in cardiac transplantation.
Patel J; Everly M; Chang D; Kittleson M; Reed E; Kobashigawa J
J Heart Lung Transplant; 2011 Dec; 30(12):1320-6. PubMed ID: 21968130
[TBL] [Abstract][Full Text] [Related]
13. Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience.
Thielke JJ; West-Thielke PM; Herren HL; Bareato U; Ommert T; Vidanovic V; Campbell-Lee SA; Tzvetanov IG; Sankary HN; Kaplan B; Benedetti E; Oberholzer J
Transplantation; 2009 Jan; 87(2):268-73. PubMed ID: 19155983
[TBL] [Abstract][Full Text] [Related]
14. Desensitization for sensitized patients awaiting heart transplant.
Byku M; Chang PP
Curr Opin Organ Transplant; 2019 Jun; 24(3):233-238. PubMed ID: 31090629
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of pre- heart transplantation desensitization in a series of highly sensitized patients bridged with left ventricular assist devices.
Saadi TA; Lawrecki T; Narang N; Joshi A; Sciamanna C; Pauwaa S; Macaluso G; Tatooles A; Pappas P; Cotts W; Andrade A
J Heart Lung Transplant; 2021 Oct; 40(10):1107-1111. PubMed ID: 34281777
[TBL] [Abstract][Full Text] [Related]
16. Multicenter evaluation of a national organ sharing policy for highly sensitized patients listed for heart transplantation in Canada.
Clarke B; Ducharme A; Giannetti N; Kim D; McDonald M; Pflugfelder P; Rajda M; Sénéchal M; Stadnick E; Toma M; Zieroth S; Isaac D
J Heart Lung Transplant; 2017 May; 36(5):491-498. PubMed ID: 28162932
[TBL] [Abstract][Full Text] [Related]
17. Desensitization protocol for highly sensitized renal transplant patients: a single-center experience.
Kute VB; Vanikar AV; Trivedi HL; Shah PR; Goplani KR; Patel HV; Gumber MR; Patel RD; Kanodia KV; Suthar KS; Trivedi VB; Modi PR
Saudi J Kidney Dis Transpl; 2011 Jul; 22(4):662-9. PubMed ID: 21743208
[TBL] [Abstract][Full Text] [Related]
18. Successful desensitization and kidney transplantation in the presence of donor-specific anti-human leukocyte antigen antibodies in kidney transplant recipients.
Khan MT; Hamid RB; Sarfaraz S; Lal N; Ahmed J; Luxmi S
Saudi J Kidney Dis Transpl; 2020; 31(6):1432-1438. PubMed ID: 33565460
[TBL] [Abstract][Full Text] [Related]
19. C1q Donor-Specific Antibody Associates with Post-transplant Biopsy Findings in Highly- Sensitized Kidney Transplant Recipients.
Kuppachi S; Holanda D; Gallegos S; Field EH
Clin Transpl; 2016; 32():127-134. PubMed ID: 28564530
[TBL] [Abstract][Full Text] [Related]
20. Desensitization Protocol in Recipients of Deceased Kidney Donor With Donor-Specific Antibody-Low Titers.
Kanter Berga J; Sancho Calabuig A; Gavela Martinez E; Puig Alcaraz N; Avila Bernabeu A; Crespo Albiach J; Molina Vila P; Beltrán Catalan S; Pallardó Mateu L
Transplant Proc; 2016 Nov; 48(9):2880-2883. PubMed ID: 27932097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
